Simris Alg AB (publ)
Research Simris Alg AB (publ) (SIMRIS-B) on Bullrun: market cap SEK 124.45M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSIMRIS-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 124.45M
- Financial periodQ4 2025
- RevenueSEK 285.00K
- Net income-SEK 7.22M
- Free cash flow-SEK 4.32M
- Gross margin255.4%
Valuation Snapshot
latest market cap is SEK 124.45M.
About Simris Alg AB (publ)
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
Frequently asked questions
What is Simris Alg AB (publ)'s market cap?
Simris Alg AB (publ)'s market capitalization is SEK 124.45M.
What does Simris Alg AB (publ) do?
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products;